HOME
 

History & 
Responsibilities of 
SCOT
Saudi Directory 
for Organ 
Transplantation
Saudi Guidelines 
National Brain 
Death Protocol
Regulations & 
Procedures
Coordination 
System of SCOT
Training Program
Journal of Kidney 
Diseases & 
Transplantation
Annual Reports
Riyadh Nephrology
and
Transplatation Club
Activities of the 
Deparments of 
SCOT 
News 
Printable Forms




Our toll free
number:
800-124-5500

Peritoneal Dialysis

CAPD, CCPD, and IPD should be offered as an alternative to chronic renal failure, in any dialysis unit, and this modality of therapy should be available at least in a referral hospital in any region. CAPD is preferable to IPD, APD (automated) should be available for clinical necessity (high transporter status of preitoneum and loss of ultrafiltration), psychological reasons or in small children.


  • Personal
  • A trained nephrologist ratio of one for every 50 patients.

  • A trained nurse ratio of one to 20 patients.

  • Dietician ratio 1:50 patients.

  • Social worker ratio 1:50 patients.
  • Dialysis Unit
  • A room inside or close to the hemodialysis unit should be available for training and follow-up of CAPD patients.

  • Basic equipment: a scale, fluids heaters, illustrative posters and movable chairs should be available.

  • An operation manual should be established in any CAPD clinic by the treating team (procedures, follow-ups, and protocol of therapy etc.).

^Back to top
^Back to top
  • CAPD systems
  • Disconnect (Y) shape connecting systems are superior to the earlier (straight) systems.

  • Solutions for CAPD.
  • Regulations of practice
    Those standards listed for patients on hemodialysis which apply equally to peritoneal dialysis are:
  • Correction of Anemia.

  • Nutritional status.

  • Biochemical profiles.

  • Prevention of transmissible.

  • Infections to patients and staff.

  • Correction of acidosis is readily achieved by the use of higher lactate PD fluids and calcium carbonate. The steady state serum bicarbonate level should be within the normal range.

  • Peritoneal equilibration test is recommended in special situations of loss of ultrafiltration and poor biochemical control.

  • Dialysis adequacy: Current targets of adequacy of dialysis by CAPD. Weekly KT/V of urea > 1.7. Total weekly creatinine clearance > 50 L. at protein intake > 1.0 g/kg/day.

  • The minimum recommended standard for acceptable rates of peritonitis and its evaluation. Peritonitis rate < 1 episode / 18 patients months. Culture negative rate < 10%. Initial cure rate of peritonitis > 80% (without removal of catheter).

  • Guidelines for insertion of peritoneal access catheters and subsequent care have been published.

  • Outcome measures of patients and technique survival are functions of case-mix, availability of appropriate dialysis facility and patient related factors. Similar recommendations to survival data of hemodialysis apply here.

Transplantation

  • Personnel
    Specifications are available at SCOT for the qualifications required of the personnel in a transplant center.

  • Transplant center
    Specifications are available at SCOT for transplant centers (see regulations of transplantation on our web site).

  • The protocol of the most commonly used medications in immunosuppression is available at SCOT.

  • Regulation of practice.

It is advised to check the directory of the regulations of organ transplantation in the Kingdom of Saudi Arabia for selection of donors and recipients of kidney transplants (see regulations of transplantation on our web site).

  • Survival of patients and grafts
    depends on the comorbid conditions at time of transplantation. However, one year patient survival > 95% and subsequent annual death rate of <5% can be achieved. First cadaveric grafts survival should exceed 80% at one year and 70% at five years. Grafts survival in highly sensitized patients (PRA > 85%) and other high risk groups (for example some diabetics) is less (approximately 75% at one year). Patient and allograft survival with well matched life related donors should be close to 100% and 90% respectively at one year with subsequent annual death and graft failure rates of <2.5%. A method of assessing graft survival, with exclusion of functioning grafts lost because of a patient's death from other causes, is appropriate.